Article Information
History
- July 31, 2015.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- E. Hernandez-Garzón1,2,
- A.M. Fernandez1,2,
- A. Perez-Alvarez1,3,
- S. Mederos1,
- P. Perez-Domper1,2,
- P. Bascuñana4,
- R.F. de la Rosa4,
- M. Delgado4,
- M.A. Pozo4,
- A. Miranda-Vizuete5,
- D. Guerrero-Gomez5,
- E. Moreno2,6,
- P.J. McCormick2,6,7,
- A. Santi1,2,
- L. Genis1,2,
- A. Trueba1,2,
- C. Garcia-Caceres8,
- M.H. Tschöp8,
- A. Araque1,
- G. Perea1,
- E.D. Martin9 and
- I. Torres Aleman1,2,1
- 1Cajal Institute, CSIC, Madrid, Spain
- 2Ciberned, Spain
- 3Eppendorf Center for Molecular Neurobiology Hamburg, Germany
- 4Pluridisciplinary Institute, Complutense University, Madrid, Spain
- 5Institute of Biomedicine (IBiS), Virgen del Rocío Hospital/CSIC/University of Seville, Seville, Spain
- 6Dept Biochemistry and Molecular Biology, University of Barcelona, Spain
- 7School of Pharmacy, University of East Anglia, Norwich, UK
- 8Institute for Diabetes and Obesity, Munich, Germany
- 9Science and Technology Park, Institute for Research in Neurological Disabilities, University of Castilla-La Mancha, Albacete, Spain
- ↵1 Correspondence to: Ignacio Torres Aleman. Cajal Institute. Avda Dr Arce 37, Madrid 28002. Spain